Inspire Corporate Bond ETF (IBD)
ARCA ARCA Primary 
One AI Cooling Stock Is 10% Off Highs. Why IBD Says the Setup ‘Doesn't Get Much Better'
The AI buildout's real bottleneck is the steel, copper, and chilled water surrounding the GPUs.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
A smart beta exchange traded fund, the Inspire Corporate Bond ETF (IBD) debuted on 07/10/2017, and offers broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Designed to provide broad exposure to the Investment Grade Corporate Bond ETFs category of the market, the Inspire Corporate Bond ETF (IBD) is a smart beta exchange traded fund launched on 07/10/2017.
SpaceX IPO: Inside Elon Musk's $1.75 Trillion Bet On Rockets, Satellites And AI | IBD
SpaceX is eyeing the largest IPO in history. With a $1.75 trillion valuation, investors finally have a shot at owning a piece of Elon Musk's unified space and AI empire.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Designed to provide broad exposure to the Investment Grade Corporate Bond ETFs category of the market, the Inspire Corporate Bond ETF (IBD) is a smart beta exchange traded fund launched on 07/10/2017.
Palisade Bio: Gut Prodrug For IBD With Catalysts
Palisade Bio's bull thesis centers on PALI-2108. This is a gut-targeted PDE4 prodrug aiming for local efficacy with fewer systemic PDE4 side effects. The main target indications are UC and FSCD, which promise a sizable TAM if PALI-2108 ultimately succeeds. Naturally, this means PALI's story remains early-stage and highly data-dependent. Yet, they have a compelling near-term catalyst stack.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Launched on 07/10/2017, the Inspire Corporate Bond ETF (IBD) is a smart beta exchange traded fund offering broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Launched on 07/10/2017, the Inspire Corporate Bond ETF (IBD) is a smart beta exchange traded fund offering broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
The Inspire Corporate Bond ETF (IBD) was launched on 07/10/2017, and is a smart beta exchange traded fund designed to offer broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
Designed to provide broad exposure to the Investment Grade Corporate Bond ETFs category of the market, the Inspire Corporate Bond ETF (IBD) is a smart beta exchange traded fund launched on 07/10/2017.
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
A smart beta exchange traded fund, the Inspire Corporate Bond ETF (IBD) debuted on 07/10/2017, and offers broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
J&J's Tremfya Gets FDA Nod for 2nd IBD Condition Crohn's Disease
FDA approves J&J's Tremfya for its fourth indication and the second IBD condition.
